Cagrilintide

Cagrilintide (CGL10 – 10MG) by GX Peptide Supply is a specialized acylated analogue of human amylin. Unlike traditional metabolic research compounds, Cagrilintide acts as a non-selective amylin receptor agonist (AMRA), providing a unique pathway for researchers to investigate the control of energy balance and body weight independently of or in tandem with the incretin system.

Key Research Properties:

• Dual Satiety Signaling: Investigated for its ability to activate amylin receptors and calcitonin receptors, which are critical in the neurobiological regulation of food intake and “fullness” signaling.

• Synergistic Metabolic Study: Frequently used in research models alongside GLP-1 receptor agonists (such as Semaglutide) to study the potential for enhanced weight management and glycemic control via multi-pathway activation.

• Gastric Emptying Modulation: Targeted in studies exploring the delay of gastric emptying and the subsequent slowing of postprandial glucose absorption.

• Extended Biological Half-Life: Engineered with specific fatty acid acylation to allow for prolonged research observation of amylin-mediated effects in laboratory subjects.

Product Specifications:

• Product Code: CGL10.

• Concentration: 10mg per vial.

• Format: Lyophilized (freeze-dried) powder for maximum molecular stability and peak biological activity.

• Analytical Purity: Manufactured by GX Peptide Supply to meet rigorous research standards, ensuring high sequence accuracy.

Storage & Handling Guidelines:

• Temperature: Store non-reconstituted vials at -20°C for optimal long-term shelf life.

• Light Protection: Provided in specialized light-resistant vials to prevent UV-induced degradation of the peptide chain.

• Reconstitution: For best results, use sterile laboratory-grade solvents under aseptic conditions; avoid mechanical stress or vigorous agitation.